Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Zinc Supplementation on Insulin Resistance and Clinical Features in Women With Polyendocrine Metabolic Ovarian Syndrome: A Randomized, Double Blind Placebo-Controlled Trial.

NCT07801001 is registered in ClinicalTrials.gov with Bangladesh Medical University as lead sponsor.

NCT NCT07801001
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07801001 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Zinc Supplementation on Insulin Resistance and Clinical Features in Women With Polyendocrine Metabolic Ovarian Syndrome: A Randomized, Double Blind Placebo-Controlled Trial.
Lead sponsor
Bangladesh Medical University
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
February 28, 2027
Completion date
July 31, 2027
Enrollment
74 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

polyendocrine metabolic ovarian syndrome (pmos)